Ondansetron Injection
Product Images NDC 68083-113

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68083-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ondansetron Spl Label

Ondansetron Injection USP 4 mg/2 mL (2 mg/mL) single-dose vial label showing it is sterile and intended for intravenous or intramuscular injection. Manufactured by Gland Pharma Limited, Hyderabad, India. The label includes the NDC 68083-113-01, a barcode space, and fields for lot number and expiration date.*

FDA Label Image

Ondansetron Spl Structure

Chemical structure of Ondansetron hydrochloride dihydrate depicted in a 2D molecular diagram showing rings and functional groups typical for the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.